Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 100,395 | 99,734 | 91,713 | 99,465 | 86,242 |
| Operating Income | -100,395 | -99,734 | -91,713 | -99,465 | -86,242 |
| Other Income | 777 | 385 | 106 | 135 | 120 |
| Pre-tax Income | -99,618 | -99,349 | -91,607 | -99,330 | -86,122 |
| Net Income Continuous | -99,618 | -99,349 | -91,607 | -99,330 | -86,122 |
| Net Income | $-99,618 | $-99,349 | $-91,607 | $-99,330 | $-86,122 |
| EPS Basic Total Ops | -0.63 | -0.63 | -0.58 | -0.64 | -0.55 |
| EPS Basic Continuous Ops | -0.63 | -0.63 | -0.58 | -0.64 | -0.55 |
| EPS Diluted Total Ops | -0.63 | -0.63 | -0.58 | -0.64 | -0.55 |
| EPS Diluted Continuous Ops | -0.63 | -0.63 | -0.58 | -0.64 | -0.55 |
| EBITDA(a) | $-94,065 | $-95,027 | $-86,194 | $-94,165 | $-80,962 |